Molecular Oncology
Volume 3, Issue 5 , Pages 451-463 , December 2009

Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells

  • Rizwan Hamid

      Affiliations

    • Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • Corresponding Author InformationCorresponding author. Division of Medical Genetics, Room DD-2205, Medical Center North, Vanderbilt University Medical Center, Nashville, TN 37232, United States. Tel.: +1 615 322 7601; fax: +1 343 936 9951.
    • ,
  • Stephen J. Brandt

      Affiliations

    • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • Vanderbilt-Ingram Cancer Center of Vanderbilt University Medical Center, Nashville, TN 37232, United States
    • VA Tennessee Valley Healthcare System, Nashville, TN 37232, United States

Received 6 February 2009 ,Revised 29 June 2009 ,Accepted 13 July 2009.

References 

  1. Bartholin L, Powers SE, Melhuish TA, Lasse S, Weinstein M, Wotton D. TGIF inhibits retinoid signaling. Mol. Cell. Biol. 2006;26(3):990–1001
  2. Batard P, Monier MN, Fortunel N, Ducos K, Sansilvestri-Morel P, Phan T, et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J. Cell. Sci. 2000;113(Pt 3):383–390
  3. Belloni E, Muenke M, Roessler E, Traverso G, Siegel-Bartelt J, Frumkin A, et al. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat. Genet. 1996;14(3):353–356
  4. Bernardi R, Papa A, Pandolfi PP. Regulation of apoptosis by PML and the PML-NBs. Oncogene. 2008;27(48):6299–6312
  5. Bertolino E, Reimund B, Wildt-Perinic D, Clerc RG. A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif. J. Biol. Chem. 1995;270(52):31178–31188
  6. Brown SA, Warburton D, Brown LY, Yu CY, Roeder ER, Stengel-Rutkowski S, et al. Holoprosencephaly due to mutations in ZIC2, a homologue of drosophila odd-paired. Nat. Genet. 1998;20(2):180–183
  7. Brynczka C, Labhart P, Merrick BA. NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation. BMC. Genomics. 2007;8:139
  8. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia. 2002;16(10):1896–1905
  9. de la Cruz JM, Bamford RN, Burdine RD, Roessler E, Barkovich AJ, Donnai D, et al. A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects. Hum. Genet. 2002;110(5):422–428
  10. Evans T. Regulation of hematopoiesis by retinoid signaling. Exp. Hematol. 2005;33(9):1055–1061
  11. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell. 1993;74(6):1009–1020
  12. Faresse N, Colland F, Ferrand N, Prunier C, Bourgeade MF, Atfi A. Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling. Embo. J. 2008;27(13):1804–1815
  13. Gaines P, Berliner N. Retinoids in myelopoiesis. J. Biol. Regul. Homeost. Agents. 2003;17(1):46–65
  14. Gaines P, Berliner N. Differentiation and characterization of myeloid cells. Cur. Protocols Immunol. Suppl. 2005;67:
  15. Garbe A, Spyridonidis A, Mobest D, Schmoor C, Mertelsmann R, Henschler R. Transforming growth factor-beta 1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells. Br. J. Haematol. 1997;99(4):951–958
  16. Hamid R, Means-Powell J, Martincic D, Kravtsov VD, Shyr Y, Greer JP, Byrne DW, Koury MJ, Brandt SJ. Expression of the TG-Interacting Factor Gene in Blast Cells at Diagnosis Correlates with Patient Survival in Acute Myeloid Leukemia. Blood, Submitted for publication.
  17. Hamid R, Patterson J, Brandt SJ. Genomic structure, alternative splicing and expression of TG-interacting factor, in human myeloid leukemia blasts and cell lines. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms. 2008;1779:347–355
  18. Hobbs S, Jitrapakdee S, Wallace JC. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem. Biophys. Res. Commun. 1998;252(2):368–372
  19. Horie T, Ono K, Kinoshita M, Nishi H, Nagao K, Kawamura T, et al TG-interacting factor is required for the differentiation of preadipocytes. J. Lipid Res. 2008;
  20. Iwasaki H, Akashi K. Myeloid lineage commitment from the hematopoietic stem cell. Immunity. 2007;26(6):726–740
  21. Kastner P, Chan S. Function of RARalpha during the maturation of neutrophils. Oncogene. 2001;20(49):7178–7185
  22. Kim SJ, Letterio J. Transforming growth factor-beta signaling in normal and malignant hematopoiesis. Leukemia. 2003;17(9):1731–1737
  23. Klages N, Zufferey R, Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2000;2(2):170–176
  24. Larsson J, Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene. 2005;24(37):5676–5692
  25. Lawson ND, Berliner N. Neutrophil maturation and the role of retinoic acid. Exp. Hematol. 1999;27(9):1355–1367
  26. Le Cabec V, Calafat J, Borregaard N. Sorting of the specific granule protein, NGAL, during granulocytic maturation of HL-60 cells. Blood. 1997;89(6):2113–2121
  27. Lee KY, Bae SC. TGF-beta-dependent cell growth arrest and apoptosis. J. Biochem. Mol. Biol. 2002;35(1):47–53
  28. Mar L, Hoodless PA. Embryonic fibroblasts from mice lacking TGIF were defective in cell cycling. Mol. Cell. Biol. 2006;26(11):4302–4310
  29. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc. Natl. Acad. Sci. U S A. 2005;102(3):749–754
  30. Ming JE, Kaupas ME, Roessler E, Brunner HG, Golabi M, Tekin M, et al. Mutations in PATCHED-1, the receptor for SONIC HEDGEHOG, are associated with holoprosencephaly. Hum. Genet. 2002;110(4):297–301
  31. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124(6):1283–1298
  32. Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood. 2006;107(8):3330–3338
  33. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996;272(5259):263–267
  34. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121(3):335–348
  35. Phillips RL, Ernst RE, Brunk B, Ivanova N, Mahan MA, Deanehan JK, et al. The genetic program of hematopoietic stem cells. Science. 2000;288(5471):1635–1640
  36. Purton EL. Roles of retinoids and retinoic Acid receptors in the regulation of hematopoietic stem cell self-renewal and differentiation. PPAR Res. 2007;2007:87934
  37. Roessler E, Du YZ, Mullor JL, Casas E, Allen WP, Gillessen-Kaesbach G, et al. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc. Natl. Acad. Sci. U S A. 2003;100(23):13424–13429
  38. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 2007;7(2):105–117
  39. Ruegemer JJ, Ho SN, Augustine JA, Schlager JW, Bell MP, McKean DJ, et al. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression. J. Immunol. 1990;144(5):1767–1776
  40. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev. Biol. 2003;260(2):404–413
  41. Seo SR, Ferrand N, Faresse N, Prunier C, Abecassis L, Pessah M, et al. Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling. Mol. Cell. 2006;23(4):547–559
  42. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood. 1996;88(1):82–88
  43. Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS, et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA. 2003;9(4):493–501
  44. Stoeck M, Miescher S, MacDonald HR, Von Fliedner V. Transforming growth factors beta slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line. J. Cell. Physiol. 1989;141(1):65–73
  45. van der Vos KE, Coffer PJ. FOXO-binding partners: it takes two to tango. Oncogene. 2008;27(16):2289–2299
  46. Verbeek W, Lekstrom-Himes J, Park DJ, Dang PM, Vuong PT, Kawano S, et al. Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood. 1999;94(9):3141–3150
  47. Wallis DE, Roessler E, Hehr U, Nanni L, Wiltshire T, Richieri-Costa A, et al. Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat. Genet. 1999;22(2):196–198
  48. Wotton D, Knoepfler PS, Laherty CD, Eisenman RN, Massague J. The Smad transcriptional corepressor TGIF recruits mSin3. Cell. Growth. Differ. 2001;12(9):457–463
  49. Wotton D, Lo RS, Lee S, Massague J. A Smad transcriptional corepressor. Cell. 1999;97(1):29–39
  50. Wotton D, Lo RS, Swaby LA, Massague J. Multiple modes of repression by the Smad transcriptional corepressor TGIF. J. Biol. Chem. 1999;274(52):37105–37110
  51. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. Proc. Natl. Acad. Sci. U S A. 1997;94(24):13187–13192
  52. Zhang H, Li N, Tang Y, Wu W, Zhang Q, Yu Z. Negative functional interaction of retinoic acid and TGF-beta signaling mediated by TG-interacting factor during chondrogenesis. Cell. Physiol. Biochem. 2009;23(1–3):157–164
  53. Zhuang Y, Faria TN, Chambon P, Gudas LJ. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Mol. Cancer Res. 2003;1(8):619–630
  54. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997;15(9):871–875

PII: S1574-7891(09)00087-8

doi: 10.1016/j.molonc.2009.07.004

Molecular Oncology
Volume 3, Issue 5 , Pages 451-463 , December 2009

Article Tools

* Image Usage & Resolution